02126 JW THERAP-B
- 1.290
- 0.0000.00%
JW THERAP-B News
JW THERAP-B: GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARE UNITS
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
JW THERAP-B: CHANGE OF AUDITOR
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
JW THERAP-B: 2024 INTERIM REPORT
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
JW THERAP-B: GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARE UNITS
JW THERAP-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
JW THERAP-B: CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE OF COMPOSITION OF BOARD COMMITTEES
JW THERAP-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
JW THERAP-B: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE NMPA ACCEPTANCE OF SUPPLEMENTAL BIOLOGICAL LICENSE APPLICATION OF CARTEYVA IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY MENTLE CELL LYMPHOMA
JW THERAP-B: NOTICE OF BOARD MEETING
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
JW THERAP-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
JW THERAP-B: CHANGE OF CHIEF EXECUTIVE OFFICER, APPOINTMENT, REDESIGNATION AND RESIGNATION OF DIRECTORS, CHANGE OF COMPOSITION OF BOARD COMMITTEES AND CHANGE OF AUTHORIZED REPRESENTATIVE
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
JW THERAP-B: NINTH AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION
JW THERAP-B: POLL RESULTS OF THE ANNUAL GENERAL MEETINGHELD ON JUNE 18, 2024
No Data
